Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised Feasibility Trial to Define Outcome Measures for Acute Charcot Neuroarthropathy in Diabetes and Their Use in Assessing Clinical Management (CADOM)

NCT05104944 is registered in ClinicalTrials.gov with Norfolk and Norwich University Hospitals NHS Foundation Trust as lead sponsor.

NCT NCT05104944
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05104944 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised Feasibility Trial to Define Outcome Measures for Acute Charcot Neuroarthropathy in Diabetes and Their Use in Assessing Clinical Management (CADOM)
Lead sponsor
Norfolk and Norwich University Hospitals NHS Foundation Trust
Phase
Not applicable
Overall status
Completed
Start date
November 20, 2017
Completion date
May 4, 2021
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes